1048 related articles for article (PubMed ID: 19809275)
1. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children.
Yélamos O; Arva NC; Obregon R; Yazdan P; Wagner A; Guitart J; Gerami P
Am J Surg Pathol; 2015 Mar; 39(3):405-15. PubMed ID: 25517953
[TBL] [Abstract][Full Text] [Related]
5. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study.
Mesbah Ardakani N; Singh S; Thomas C; Van Vliet C; Harvey NT; Calonje JE; Wood BA
Am J Dermatopathol; 2021 Mar; 43(3):182-190. PubMed ID: 32649342
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
9. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
10. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
11. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
[TBL] [Abstract][Full Text] [Related]
12. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
Gerami P; Geraminegad P
G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
[TBL] [Abstract][Full Text] [Related]
15. Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma.
Yélamos O; Busam KJ; Lee C; Meldi Sholl L; Amin SM; Merkel EA; Obregon R; Guitart J; Gerami P
J Cutan Pathol; 2015 Nov; 42(11):796-806. PubMed ID: 26356543
[TBL] [Abstract][Full Text] [Related]
16. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
17. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
18. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
19. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in melanocytic lesions of the skin.
Ramirez JA; Guitart J; Rao MS; Diaz LK
Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]